Trial Profile
Effectiveness of Posaconazole as Salvage Treatment After 2 Weeks of Preemptive Antifungal Treatment
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase IV
Latest Information Update: 11 May 2022
Price :
$35
*
At a glance
- Drugs Posaconazole (Primary)
- Indications Aspergillosis
- Focus Therapeutic Use
- 11 Dec 2014 Status changed from not yet recruiting to withdrawn prior to enrolment as reported by ClinicalTrials.gov record.
- 04 Jan 2014 New trial record